Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) — The global negative pressure wound therapy market, valued at US$2.59 billion in 2024, stood at US$2.76 billion in 2025 and is projected to advance at a resilient CAGR of 6.9% from 2025 to 2030, culminating in a forecasted valuation of US$3.84 billion by the end of the period. This growth is fueled by increasing rates of diabetes, surging incidences of traumatic and burn injuries, a rapidly aging population, and supportive government and industry initiatives.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=215139824
Why This Matters Now for Industry Leaders
Chronic wounds already impact up to 2% of the global population, with foot ulcers affecting roughly a quarter of diabetic patients. Rising surgical volumes, road traffic accidents, and geriatric healthcare demands are pushing hospitals, home care providers, and insurers to adopt NPWT as a standard of care. The shift towards simplified, single-use NPWT devices is also unlocking new growth opportunities in outpatient and resource-limited settings—reducing overall treatment costs without compromising clinical outcomes.
Key Market Drivers
- Escalating Trauma Cases: Countries such as Brazil, India, China, and the U.S. are witnessing rising road accident fatalities, spurring investment in trauma care infrastructure and advanced wound management.
- Growing Chronic Disease Burden: Diabetes-related complications, particularly foot ulcers, continue to drive NPWT adoption in hospitals and home care.
- Favorable Policy Landscape: Reimbursement support and targeted government healthcare programs are accelerating access to NPWT products in high-income markets.
Industry Challenges and Opportunities
While high device costs remain a …